Clinical presentation of Lyme-associated uveitis is poorly described. We reported here a case series of seven patients with uveitis related to Lyme disease and a review of the literature.
Methods:
A retrospective study in our university hospital between 1 May 2003 and 31 July 2016 on 1006 uveitis patients and review of Pubmed library.
Results:
Seven patients (71.4% male, mean age = 53 (38–70)) were diagnosed with a Lyme-associated uveitis. All anatomical types of uveitis were found (four intermediate, three anterior, and three posterior uveitis); most were unilateral (n = 6; 85.7%), one granulomatous and two with synechiae. Peripheral retinal vasculitis was present in four patients. They all had a risk of exposure or extra-ophthalmological symptoms. Antibiotic and steroid treatment was rapidly effective in all patients. Four patients presented recurrences of uveitis, of whom two received a second antibiotic treatment, which is quite common in literature. Persistent or recurrence of symptoms can be explained by three hypotheses: (1) reinfection, (2) relapse of original infection, and (3) autoimmune reaction.
Conclusion:
Lyme-associated uveitis appears varied. Hyalitis and involvement of the posterior segment and retinal vasculitis seem to be rather frequent. Its prognosis is mainly good, even if inflammation can be resistant or recurring.
MackensenFZimmermannSAlleW, et al. Difficulties of interpreting Borrelia serology in patients with uveitis. Ocul Immunol Inflamm2011; 19: 227–231.
10.
BrownSLHansenSLLangoneJJ.Role of serology in the diagnosis of Lyme disease. JAMA1999; 282: 62–66.
11.
BernardAKodjikianLAbukhashabhA, et al. Diagnosis of Lyme-associated uveitis: value of serological testing in a tertiary centre. Br J Ophthalmol2018; 102: 369–372.
Centers for Disease Control and Prevention of Lyme disease in the United States2015National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Vector-Borne Diseases (DVBD), http://www.cdc.gov/lyme/diagnosistesting/ (accessed 22 June 2016).
14.
MikkiläHOSeppäläIJViljanenMK, et al. The expanding clinical spectrum of ocular Lyme borreliosis. Ophthalmology2000; 107: 581–587.
15.
LeysAMSchönherrULangGE, et al. Retinal vasculitis in Lyme borreliosis. Bull Soc Belge Ophtalmol1995; 259: 205–214.
16.
HuppertzHMunchmeierDLiebW.Ocular manifestations in children and adolescents with Lyme arthritis. Br J Ophthalmol1999; 83: 1149–1152.
17.
SauerAHansmannYJaulhacB, et al. Les manifestations ophtalmologiques de la maladie de Lyme chez l’enfant : description de cinq cas et revue de la littérature. J Fr Ophtalmol2012; 35: 17–22.
18.
KılıçMüftüoğluIAydin AkovaYGür GüngörS. A case of Lyme disease accompanied by uveitis and white dot syndrome. Turk J Ophthalmol2016; 46: 241–243.
19.
MahneJKranjcBSStrleF, et al. Panuveitis caused by Borrelia burgdorferi sensu lato infection. Pediatr Infect Dis J2015; 34: 102–104.
20.
KlaegerAJHerbortCP.Cotton wool spots as possible indicators of retinal vascular pathology in ocular Lyme borreliosis. Int Ophthalmol2010; 30: 599–602.
21.
DeibenerJDe ChillouCAngioiK, et al. Dilated cardiomyopathy and panuveitis as presenting symptoms of Lyme disease. Rev Med Interne2001; 22: 65–69.
22.
Guex-CrosierYHerbortCP.Recurrent uveitis, cystoid macular edema and pericarditis in Lyme disease. Ocul Immunol Inflamm1994; 2: 111–113.
23.
BreeveldJRothovaAKuiperH.Intermediate uveitis and Lyme borreliosis. Br J Ophthalmol1992; 76: 181–182.
24.
KauffmannDJWormserGP.Ocular Lyme disease: case report and review of the literature. Br J Ophthalmol1990; 74: 325–327.
25.
TugwellPDennisDTWeinsteinA, et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med1997; 127: 1109–1123.
26.
SteereACDurayPHKauffmannDJ, et al. Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med1985; 103: 382–384.
27.
KarmaAPirttiläTAViljanenMK, et al. Secondary retinitis pigmentosa and cerebral demyelination in Lyme borreliosis. Br J Ophthalmol1993; 77: 120–122.
28.
PleyerUPriemSBergmannL, et al. Detection of Borrelia burgdorferi DNA in urine of patients with ocular Lyme borreliosis. Br J Ophthalmol2001; 85: 552–555.
29.
RauterCMuellerMDiterichI, et al. Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis. Clin Diagn Lab Immunol2005; 12: 910–917.
30.
LebechAMHansenKBrandrupF, et al. Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis. Mol Diagn2000; 5: 139–150.
31.
MattéiJPélissierPRichardO, et al. Lyme uveitis: 2 case reports. Arch Pediatr2011; 18: 49–53.
32.
NiculaCNiculaDRusuI, et al. Bilateral anterior uveiopapillitis, suspicious of Lyme disease—case report. Oftalmologia2013; 57: 23–31.
33.
RícarováRStruncováVPlískováS, et al. Anterior uveitis in Lyme borreliosis. Cesk Slov Oftalmol1995; 51: 34–38.
34.
GrinagerHSKrasonDAOlsenTW.Lyme disease: resolution of a serous retinal detachment and chorioretinal folds after antibiotic therapy. Retin Cases Brief Rep2012; 6: 232–234.
35.
NadelmanRBHanincováKMukherjeeP, et al. Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med2012; 367: 1883–1890.
36.
BuschUHizo-TeufelCBoehmerR, et al. Three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B afzelii, and B. garinii) identified from cerebrospinal fluid isolates by pulsed-field gel electrophoresis and PCR. J Clin Microbiol1996; 34: 1072–1078.
37.
LiverisDVardeSIyerR, et al. Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol1999; 37: 565–569.
38.
Ruzic-SabljicEArnezMLogarM, et al. Comparison of Borrelia burgdorferi sensu lato strains isolated from specimens obtained simultaneously from two different sites of infection in individual patients. J Clin Microbiol2005; 43: 2194–2200.
39.
StrickerRBCorsonAFJohnsonL.Reinfection versus relapse in patients with Lyme disease: not enough evidence. Clin Infect Dis2008; 46: 950; author reply 950–951.
40.
SapiEKaurNAnyanwuS, et al. Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resist2011; 4: 97–113.
41.
KerstenAPoitschekCRauchS, et al. Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi. Antimicrob Agents Chemother1995; 39: 1127–1133.
42.
BrorsonOBrorsonSH.In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection1998; 26: 144–150.
43.
OksiJMarjamäkiMNikoskelainenJ, et al. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann Med1999; 31: 225–232.
44.
ChandraAWormserGPKlempnerMS, et al. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun2010; 24: 1018–1024.
45.
SoulasPWoodsAJaulhacB, et al. Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection. J Clin Invest2005; 115: 2257–2267.
